Skip to content
Sign in

DRIO · NASDAQ

DarioHealth (DRIO) Stock Price & Fundamentals

$272.43−0.46%−$1.27End-of-day price as of Oct 9, 2026

DarioHealth (DRIO) closed at $272.43 on Oct 9, 2026, down 0.46% from the previous close of $273.70.

Share price, past year

1Y +6.56%

52-week range $247.81 – $301.76. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$272.43
Sep 30, 2026$271.92
Aug 31, 2026$261.19
Jul 31, 2026$271.26
Jun 30, 2026$247.81
May 29, 2026$265.32
Apr 30, 2026$281.43
Mar 31, 2026$288.41
Feb 27, 2026$282.32
Jan 30, 2026$286.84
Dec 31, 2025$279.29
Nov 28, 2025$266.37
Oct 31, 2025$263.20

Key statistics

Market cap
$2.00B
P/E (TTM)
46.9
EPS (TTM)
$5.81
Revenue (TTM)
$21.00M
Net income (TTM)
−$35.67M
Shares outstanding
7.3M
Dividend yield
—
52-week range
$247.81 – $301.76

DarioHealth's market cap is $2.00B, based on a share price of $272.43 and 7.3M shares outstanding as of Jun 30, 2026.

Financials

DarioHealth reported revenue of $22.36M for fiscal 2025, down 17.31% from fiscal 2024.

DarioHealth reported a net loss of $41.71M in fiscal 2025.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
DarioHealth annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$22.36M−17.3%−$41.71M−186.6%$10.12−$26.08M
FY2024ended Dec 31, 2024$27.04M+32.9%−$42.75M−158.1%$12.27−$38.70M
FY2023ended Dec 31, 2023$20.35M−26.4%−$59.43M−292.0%$38.60−$30.96M
FY2022ended Dec 31, 2022$27.66M+34.8%−$62.19M−224.9%$50.80−$48.29M
FY2021ended Dec 31, 2021$20.51M+170.8%−$76.76M−374.2%$81.40−$50.67M
FY2020ended Dec 31, 2020$7.58M+0.2%−$29.45M−388.7%$80.20−$17.85M
FY2019ended Dec 31, 2019$7.56M+2.2%−$17.74M−234.6%$160.00−$15.82M
FY2018ended Dec 31, 2018$7.39M+43.0%−$17.80M−240.8%$312.60−$11.54M
FY2017ended Dec 31, 2017$5.17M+84.5%−$15.74M−304.5%$32.80−$10.81M
FY2016ended Dec 31, 2016$2.80M—−$10.89M−388.4%$41.80−$9.19M
DarioHealth quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$5.18M−$7.92M$0.85
Q1 FY2026ended Mar 31, 2026$5.58M−$8.25M$1.25
Q4 FY2025ended Dec 31, 2025$5.23M−$9.03M$0.75
Q3 FY2025ended Sep 30, 2025$5.01M−$10.47M$2.96
Q2 FY2025ended Jun 30, 2025$5.37M−$12.99M$3.54
Q1 FY2025ended Mar 31, 2025$6.75M−$9.23M$2.87
Q4 FY2024ended Dec 31, 2024$7.60M−$9.63M$1.76
Q3 FY2024ended Sep 30, 2024$7.42M−$12.33M$4.91

Company profile

Name
DarioHealth Corp.
Ticker
DRIO
Exchange
NASDAQ
Industry (SEC SIC)
Surgical & Medical Instruments & Apparatus
Headquarters
322 W 57th St. #33b, New York, NY 10019
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001533998

Recent SEC filings

Frequently asked questions

What is DarioHealth's stock price?

DarioHealth (DRIO) closed at $272.43 on Oct 9, 2026, down 0.46% from the previous close of $273.70.

What is DarioHealth's market cap?

DarioHealth's market cap is $2.00B, based on a share price of $272.43 and 7.3M shares outstanding as of Jun 30, 2026.

How much revenue does DarioHealth make?

DarioHealth reported revenue of $22.36M for fiscal 2025, down 17.31% from fiscal 2024.

What is DRIO's P/E ratio?

DarioHealth's price-to-earnings ratio is 46.9, based on trailing twelve-month diluted EPS of $5.81.

Does DarioHealth pay a dividend?

DarioHealth's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from DarioHealth Corp.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures